Skip to main content

Want a detailed portfolio tracker?

Incyte (INCY) P/E (2010 - 2026)

Incyte (INCY) P/E from Mar 31, 2010 to Jun 12, 2026. The TTM Incyte (INCY) P/E is 14.92. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Incyte (INCY)

YearP/EChange
202614.92-0.70%
202515.03-99.42%
20242.59K+7727.87%
202333.04+62.73%
202220.30+18.78%
202117.09-127.06%
2020-63.16-250.21%
201942.05-66.05%
2018123.85-199.04%
2017-125.04-200.15%
2016124.86-96.72%
20153.81K-1595.05%
2014-254.94+168.11%
2013-95.09+99.58%
2012-47.64+148.16%
2011-19.20-58.09%
2010-45.80N/A

Comparison Incyte (INCY) P/E with competitors

Incyte (INCY) P/E is 14.92.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-99.99%
NBYStablecoin Development Corp0.00-99.97%
ENLVEnlivex Therapeutics Ltd0.13-99.13%
FGENFibroGen Inc0.24-98.39%
TRAWTraws Pharma Inc0.47-96.83%
FBIOFortress Biotech Inc0.71-95.25%
CHRSCoherus Biosciences Inc0.80-94.63%
ORMPOramed Pharmaceuticals Inc1.37-90.82%
AGENAgenus Inc1.84-87.64%
VIVSVivoSim Labs Inc2.32-84.45%
INVAInnoviva Inc3.31-77.79%
CRMDCorMedix Inc3.78-74.67%
VXRTVaxart Inc3.95-73.52%
ABEOAbeona Therapeutics Inc3.96-73.45%
SRPTSarepta Therapeutics Inc4.19-71.93%
CVACCureVac N.V.4.45-70.20%
GLPGGalapagos NV4.86-67.44%
ABUSArbutus Biopharma Corp5.06-66.12%
RIGLRigel Pharmaceuticals5.16-65.43%
CGENCompugen Ltd5.24-64.86%
ZVRAZevra Therapeutics Inc6.13-58.90%
OMEROmeros Corporation9.11-38.96%
PLXProtalix BioTherapeutics Inc9.21-38.29%
SPROSpero Therapeutics Inc9.31-37.63%
AUPHAurinia Pharmaceuticals Inc9.32-37.52%
ACADAcadia Pharmaceuticals Inc9.62-35.56%
TBPHTheravance Biopharma Inc11.86-20.54%
ADMAAdma Biologics Inc12.13-18.69%
SABSSAB Biotherapeutics Inc12.93-13.37%
HRMYHarmony Biosciences Holdings Inc14.05-5.84%
REGNRegeneron Pharmaceuticals Inc14.36-3.77%
PBYIPuma Biotechnology Inc14.45-3.13%
NAGENiagen Bioscience Inc14.82-0.69%
XOMAXOMA Corp14.95+0.22%
TGTXTG Therapeutics Inc15.67+5.05%
EXELExelixis Inc16.60+11.26%
CPRXCatalyst Pharmaceuticals Inc17.36+16.32%
MDXGMimedx Group Inc17.52+17.42%
CTMXCytomX Therapeutics Inc19.63+31.55%
ASNDAscendis Pharma A/S23.50+57.51%
HALOHalozyme Therapeutics Inc23.83+59.69%
ARGXArgen X SE24.24+62.46%
XOMAOXOMA Corp25.34+69.87%
VRTXVertex Pharmaceuticals Inc25.57+71.36%
XOMAPXOMA Corp25.67+72.05%
RPRXRoyalty Pharma plc - Class A27.78+86.16%
SLNOSoleno Therapeutics Inc29.02+94.47%
LGNDLigand Pharmaceuticals Inc - Class B31.77+112.91%
APLSApellis Pharmaceuticals Inc39.02+161.53%
BMRNBiomarin Pharmaceutical Inc40.22+169.57%
KRYSKrystal Biotech Inc40.45+171.08%
ONCBeiGene Ltd58.89+294.73%
PHARPharming Group N.V.68.77+360.95%
TECHBio-Techne Corp74.88+401.90%
VCELVericel Corp87.95+489.44%
GMABGenmab118.15+691.86%
ALNYAlnylam Pharmaceuticals Inc123.07+724.85%
TLXTelix Pharmaceuticals Ltd135.58+808.71%
CORTCorcept Therapeutics Inc185.65+1144.26%